JP2007512807A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512807A5
JP2007512807A5 JP2006537114A JP2006537114A JP2007512807A5 JP 2007512807 A5 JP2007512807 A5 JP 2007512807A5 JP 2006537114 A JP2006537114 A JP 2006537114A JP 2006537114 A JP2006537114 A JP 2006537114A JP 2007512807 A5 JP2007512807 A5 JP 2007512807A5
Authority
JP
Japan
Prior art keywords
markers
marker
fragment
cancer
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006537114A
Other languages
English (en)
Other versions
JP2007512807A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/011599 external-priority patent/WO2005047534A2/en
Publication of JP2007512807A publication Critical patent/JP2007512807A/ja
Publication of JP2007512807A5 publication Critical patent/JP2007512807A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 少なくとも２つのマーカーを検出することによる癌の処置に対する応答の予測のための方法であって、該マーカーが悪性腫瘍において変化した１つの染色体領域に位置する遺伝子およびその断片またはゲノム核酸配列であることを特徴とする方法。
JP2006537114A 2003-10-28 2004-10-15 悪性腫瘍の処置に対する応答予測のための方法および組成物 Pending JP2007512807A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03024565 2003-10-28
PCT/EP2004/011599 WO2005047534A2 (en) 2003-10-28 2004-10-15 Methods and compositions for the response prediction of malig-nant neoplasia to treatment

Publications (2)

Publication Number Publication Date
JP2007512807A JP2007512807A (ja) 2007-05-24
JP2007512807A5 true JP2007512807A5 (ja) 2007-11-01

Family

ID=34585868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006537114A Pending JP2007512807A (ja) 2003-10-28 2004-10-15 悪性腫瘍の処置に対する応答予測のための方法および組成物

Country Status (4)

Country Link
US (1) US20080113344A1 (ja)
EP (1) EP1682675A2 (ja)
JP (1) JP2007512807A (ja)
WO (1) WO2005047534A2 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700299B2 (en) * 2005-08-12 2010-04-20 Hoffmann-La Roche Inc. Method for predicting the response to a treatment
WO2007081613A2 (en) * 2005-11-28 2007-07-19 Siemens Healthcare Diagnostics Inc. A kinetic pcr assay for quantification of gene amplification on chromosome 17
US8445198B2 (en) 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
EP1960551A2 (en) * 2005-12-01 2008-08-27 Medical Prognosis Institute Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US20090280493A1 (en) * 2006-09-08 2009-11-12 Siemens Healthcare Diagnostics Inc. Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia
JP2008113620A (ja) * 2006-11-07 2008-05-22 Toyobo Co Ltd ルシフェラーゼの発光方法
US20090298709A1 (en) * 2008-05-28 2009-12-03 Affymetrix, Inc. Assays for determining telomere length and repeated sequence copy number
CA2735197C (en) * 2008-09-10 2017-05-09 University Of Medicine And Dentistry Of New Jersey Imaging individual mrna molecules using multiple singly labeled probes
EP2373809A1 (en) * 2008-12-10 2011-10-12 Ipsogen Methods for identifying erbb2 alteration in tumors
KR101251538B1 (ko) 2009-04-17 2013-04-08 (주)아벨리노 아벨리노 각막이상증 진단용 프라이머
US20120065084A1 (en) * 2009-04-17 2012-03-15 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
RU2612884C2 (ru) * 2010-04-02 2017-03-13 Курна, Инк. Лечение заболеваний, связанных с колониестимулирующим фактором 3 (csf3), путем ингибирования природного антисмыслового транскрипта k csf3
WO2011135459A2 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
KR101125212B1 (ko) 2010-10-01 2012-03-21 (주)아벨리노 아벨리노 각막이상증 진단용 시스템
WO2012061759A2 (en) * 2010-11-05 2012-05-10 Morphotek Inc. Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
KR20130098938A (ko) * 2012-02-28 2013-09-05 (주)아벨리노 아벨리노 각막이상증 진단검사 신청 및 결과 확인방법
US10889850B2 (en) 2013-03-15 2021-01-12 Avellino Lab Usa, Inc. Methods for improved isolation of genomic DNA templates for allele detection
KR20210037750A (ko) 2013-03-15 2021-04-06 아벨리노 랩 유에스에이, 인크. 대립유전자 검출을 위한 게놈 dna 주형의 개선된 단리 방법
EP3068908B1 (en) 2013-11-15 2021-01-06 Avellino Lab USA, Inc. Methods for multiplex detection of alleles associated with ophthalmic conditions
US10570457B2 (en) 2014-09-26 2020-02-25 Medical Prognosis Institute A/S Methods for predicting drug responsiveness
EP3234128A4 (en) * 2014-12-16 2018-06-27 Garvan Institute of Medical Research Sequencing controls
KR101907251B1 (ko) 2015-03-10 2018-10-12 한양대학교 산학협력단 항호르몬제 내성 및 삼중-음성 유방암의 진단 및 치료를 위한 바이오마커 및 이를 포함하는 조성물
EP4036228A1 (en) 2015-11-13 2022-08-03 Avellino Lab USA, Inc. Methods for the treatment of corneal dystrophies
US9725769B1 (en) 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
AU2017258901A1 (en) 2016-12-30 2018-07-19 Allarity Therapeutics Europe ApS Methods for predicting drug responsiveness in cancer patients
TW202019955A (zh) 2018-07-31 2020-06-01 德商英麥提克生物技術股份有限公司 B*07 限制肽和肽組合的抗癌免疫治療和相關方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
EP1900827A3 (en) * 2002-05-21 2008-04-16 Bayer HealthCare AG Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia

Similar Documents

Publication Publication Date Title
JP2007512807A5 (ja)
WO2006002378A3 (en) Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
HK1250521A1 (zh) 分析細胞增殖性病症的方法和核酸
WO2006033664A8 (en) Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
WO2005123942A3 (en) Analysis of methylated nucleic acid
WO2006128195A3 (en) Methods of diagnosing and treating cancer by detection of chromosomal abnormalities
EP1985715A3 (en) ESR1 and cervical cancer
WO2005078139A3 (en) DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2007039290A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
WO2008031839A3 (en) Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof
WO2005032495A8 (en) Gene expression profiles and methods of use
WO2012018613A3 (en) Genetic make-up modifies cancer outcome
WO2009074328A3 (en) Methods and nucleic acids for analyses of lung carcinoma
WO2004047514A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2008063655A3 (en) Dna methylation markers and methods of use
WO2009097270A3 (en) Method of determining breast cancer risk
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2003070082A3 (en) Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer
JP2005530695A5 (ja)
JP2008539782A5 (ja)
WO2010007083A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
HK1126278A1 (en) Identification of non-small cell lung carcinoma (nsclc) tumors expressing pdgfr-alpha pdgfr(nsclc)
ATE491941T1 (de) Schnelle komparative genomhybridisierung